๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer

โœ Scribed by Toru Hiyama; Ken Haruma; Yasuhiko Kitadai; Hiroshi Masuda; Masaki Miyamoto; Shinji Tanaka; Masaharu Yoshihara; Fumio Shimamoto; Kazuaki Chayama


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
138 KB
Volume
97
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Mutations of an oncogene, Kโ€ras, are associated with the development and progression of many types of human cancer. To elucidate the significance of Kโ€ras mutations in gastric carcinogenesis, we examined Kโ€ras mutations in gastric cancers and in Helicobacter pyloriโ€associated chronic gastritis (H. pylori__โ€CG), which is associated with an increased risk for the gastric cancer development. Specimens of gastric cancer and H. pyloriโ€__CG were obtained from 64 gastric cancer patients with H. pyloriโ€CG, 99 cancerโ€free H. pyloriโ€CG patients and 30 H. pyloriโ€negative healthy subjects. Kโ€ras mutations were examined by polymerase chain reactionโ€single strand conformation polymorphism (PCRโ€SSCP), followed by DNA sequencing analysis. Kโ€ras mutations were detected in 4 of 48 (8.3%) gastric cancers, in 10 of 163 (6.1%) H. pyloriโ€CG and none of the 30 H. pyloriโ€negative healthy subjects. In the gastric cancer patients, mutated Kโ€ras was detected in differentiated type cancers but not in any of the undifferentiated type cancers. Kโ€ras mutations in H. pyloriโ€CG were significantly more frequent in gastric cancer patients than in cancerโ€free patients (10.9% vs. 3.0%, p = 0.044). In addition, Kโ€ras mutations in H. pyloriโ€CG were significantly more frequent in patients with Kโ€ras mutated gastric cancer than in patients with Kโ€ras unmutated gastric cancer (50.0% vs. 3.7%, p = 0.037). These data suggest that the genetic mechanism(s) of carcinogenesis differs between the differentiated type and the undifferentiated type of gastric cancer and that Kโ€ras mutations may be involved in the early stages of gastric carcinogenesis of the differentiated type. ยฉ 2001 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


p53 Codon 72 polymorphism in gastric can
โœ Toru Hiyama; Shinji Tanaka; Yasuhiko Kitadai; Masanori Ito; Masaharu Sumii; Masa ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 115 KB

## Abstract __p53__ codon 72, which produces variant proteins with an arginine (Arg) or proline (Pro), has been reported to be associated with cancers of the lung, esophagus and cervix. However, there have been no reports on the __p53__ codon 72 polymorphism in gastric cancer susceptibility in pati

Progression of chronic atrophic gastriti
โœ Hiroshi Ohata; Shintaro Kitauchi; Noriko Yoshimura; Kouichi Mugitani; Masataka I ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 93 KB ๐Ÿ‘ 1 views

We conducted a longitudinal cohort study to determine the association of Helicobacter pylori infection and the progression of chronic atrophic gastritis (CAG) with gastric cancer. A cohort of 4655 healthy asymptomatic subjects was followed for a mean period of 7.7 years. H. pylori infection was esta

Relationship of TT virus and Helicobacte
โœ Fabrizio Maggi; Santino Marchi; Claudia Fornai; Elena Tempestini; Elisabetta And ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 93 KB

## Abstract Blood and gastric tissue biopsies of 34 patients with gastritis were tested for the presence of TT virus (TTV), a ubiquitous virus found in the blood of most humans. Thirtyโ€one of these patients were TTV positive, and 27 patients had virus in both tissues. In addition, 13 of the patient

K-ras mutation in sputum of patients wit
โœ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 493 KB ๐Ÿ‘ 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle